Multiple Myeloma: Epidemiology Forecasting Intelligence

Name: Multiple Myeloma: Epidemiology Forecasting Intelligence
Brand: CmaxInsight Market Intelligence
SKU: M5E5AB6D656EN
Price: 2500 USD
Availability: InStock

February 2019 | 50 pages | ID: M5E5AB6D656EN
CmaxInsight Market Intelligence

US$ 2,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

CmaxInsight’s “Multiple Myeloma-Epidemiology Forecasting Intelligence” report provides a comprehensive analysis of the Multiple Myeloma epidemiology, providing the historical, current, and forecasted data for the United States, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and Japan during the period from 2018-2028.

Our epidemiology services include:

Incidence and prevalence
Diagnosis rate, treatment rate and mortality patterns
Epidemiology-based forecasting and disease trends
Size of different patient segments in a disease area
Population based: disease occurrence, co-morbidities and treatment patterns
Geographic - Regional - Ethnic differences

Along with the epidemiological data, the report also includes:

Disease overview, causes, symptoms, classification, risk factor, pathophysiology, diagnosis and treatment
Patient treatment journey
Treatment algorithm and guidelines
Assesses the disease risk and burden
Highlights the unmet needs
Market driver and barrier
Growth opportunities and market trend analysis

Methodology

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Epidemiology Forecast model analysis by a team of industry experts.
To generate accurate patient population estimates, utilizes a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies.
All of the sources used to generate the data and analysis have been identified in the report.

Note: Systematic review of the epidemiological literature is also provided for full transparency into research and methods. This report can be delivered to the clients within 4-5 business days.

1. REPORT INTRODUCTION

2. MULTIPLE MYELOMA EPIDEMIOLOGY OVERVIEW AT A GLANCE

3. MARKET SHARE DISTRIBUTION OF MULTIPLE MYELOMA

4. DISEASE BACKGROUND AND OVERVIEW: MULTIPLE MYELOMA

4.1. Introduction
4.2. Signs and Symptoms
4.3. Etiology
4.4. Risk Factors
4.5. Pathophysiology
4.6. Diagnostic Landscape
  4.6.1. Diagnostic Practices
  4.6.2. Diagnostic Criteria
  4.6.3. Diagnostic Recommendations
4.7. Treatment Landscape
  4.7.1. Current Treatment Practices
  4.7.2. Treatment Algorithm
  4.7.3. Treatment Recommendations

5. MULTIPLE MYELOMA EPIDEMIOLOGY

5.1. Key Findings
5.2. Assumptions & Rationale
5.3. 7MM Epidemiology

6. EPIDEMIOLOGY OF MULTIPLE MYELOMA BY COUNTRIES

7. UNITED STATES

7.1. Assumptions and Rationale
7.2. Prevalent/Incident Cases of Multiple Myeloma
7.3. Sub-Type Specific cases of Multiple Myeloma*
7.4. Sex- Specific Cases of Multiple Myeloma*
7.5. Diagnosed Cases of Multiple Myeloma
7.6. Treated Cases of Multiple Myeloma

8. EU5

8.1. Germany
  8.1.1. Assumptions and Rationale
  8.1.2. Prevalent/Incident Cases of Multiple Myeloma
  8.1.3. Sub-Type Specific cases of Multiple Myeloma*
  8.1.4. Sex- Specific Cases of Multiple Myeloma*
  8.1.5. Diagnosed Cases of Multiple Myeloma
  8.1.6. Treated Cases of Multiple Myeloma
8.2. France
  8.2.1. Assumptions and Rationale
  8.2.2. Prevalent/Incident Cases of Multiple Myeloma
  8.2.3. Sub-Type Specific cases of Multiple Myeloma*
  8.2.4. Sex- Specific Cases of Multiple Myeloma*
  8.2.5. Diagnosed Cases of Multiple Myeloma
  8.2.6. Treated Cases of Multiple Myeloma
8.3. United Kingdom
  8.3.1. Assumptions and Rationale
  8.3.2. Prevalent/Incident Cases of Multiple Myeloma
  8.3.3. Sub-Type Specific cases of Multiple Myeloma*
  8.3.4. Sex- Specific Cases of Multiple Myeloma*
  8.3.5. Diagnosed Cases of Multiple Myeloma
  8.3.6. Treated Cases of Multiple Myeloma
8.4. Spain
  8.4.1. Assumptions and Rationale
  8.4.2. Prevalent/Incident Cases of Multiple Myeloma
  8.4.3. Sub-Type Specific cases of Multiple Myeloma*
  8.4.4. Sex- Specific Cases of Multiple Myeloma*
  8.4.5. Diagnosed Cases of Multiple Myeloma
  8.4.6. Treated Cases of Multiple Myeloma
8.5. Italy
  8.5.1. Assumptions and Rationale
  8.5.2. Prevalent/Incident Cases of Multiple Myeloma
  8.5.3. Sub-Type Specific cases of Multiple Myeloma*
  8.5.4. Sex- Specific Cases of Multiple Myeloma*
  8.5.5. Diagnosed Cases of Multiple Myeloma
  8.5.6. Treated Cases of Multiple Myeloma

9. JAPAN

9.1. Assumptions and Rationale
9.2. Prevalent/Incident Cases of Multiple Myeloma
9.3. Sub-Type Specific cases of Multiple Myeloma*
9.4. Sex- Specific Cases of Multiple Myeloma*
9.5. Diagnosed Cases of Multiple Myeloma
9.6. Treated Cases of Multiple Myeloma

10. UNMET NEEDS

Appendix
Report Methodology
Sources Used
Disclaimer
About CmaxInsight
*Indication Specific
Note: Certain sections of the table of contents would vary according to the availability of information.

LIST OF TABLES

Table 1: Total Prevalent/Incident Cases of the Multiple Myeloma in 7MM
Table 2: Total Prevalent/Incident Cases of the Multiple Myeloma in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Multiple Myeloma in United States
Table 4: Sub-Type Specific Cases of the Multiple Myeloma in United States*
Table 5: Sex- Specific Cases of the Multiple Myeloma in United States*
Table 6: Diagnosed Cases of the Multiple Myeloma in United States
Table 7: Treated Cases of the Multiple Myeloma in United States
Table 8: Prevalent/Incident Cases of the Multiple Myeloma in Germany
Table 9: Sub-Type Specific Cases of the Multiple Myeloma in Germany*
Table 10: Sex- Specific Cases of the Multiple Myeloma in Germany*
Table 11: Diagnosed Cases of the Multiple Myeloma in Germany
Table 12: Treated Cases of the Multiple Myeloma in Germany
Table 13: Prevalent/Incident Cases of the Multiple Myeloma in France
Table 14: Sub-Type Specific Cases of the Multiple Myeloma in France*
Table 15: Sex- Specific Cases of the Multiple Myeloma in France*
Table 16: Diagnosed Cases of the Multiple Myeloma in France
Table 17: Treated Cases of the Multiple Myeloma in France
Table 18: Prevalent/Incident Cases of the Multiple Myeloma in Italy
Table 19: Sub-Type Specific Cases of the Multiple Myeloma in Italy*
Table 20: Sex- Specific Cases of the Multiple Myeloma in Italy*
Table 21: Diagnosed Cases of the Multiple Myeloma in Italy
Table 22: Treated Cases of the Multiple Myeloma in Italy
Table 23: Prevalent/Incident Cases of the Multiple Myeloma in Spain
Table 24: Sub-Type Specific Cases of the Multiple Myeloma in Spain*
Table 25: Sex- Specific Cases of the Multiple Myeloma in Spain*
Table 26: Diagnosed Cases of the Multiple Myeloma in Spain
Table 27: Treated Cases of the Multiple Myeloma in Spain
Table 28: Prevalent/Incident Cases of the Multiple Myeloma in UK
Table 29: Sub-Type Specific Cases of the Multiple Myeloma in UK*
Table 30: Sex- Specific Cases of the Multiple Myeloma in UK*
Table 31: Diagnosed Cases of the Multiple Myeloma in UK
Table 32: Treated Cases of the Multiple Myeloma in UK
Table 33: Prevalent/Incident Cases of the Multiple Myeloma in Japan
Table 34: Sub-Type Specific Cases of the Multiple Myeloma in Japan*
Table 35: Sex- Specific Cases of the Multiple Myeloma in Japan*
Table 36: Diagnosed Cases of the Multiple Myeloma in Japan
Table 37: Treated Cases of the Multiple Myeloma in Japan

*Indication Specific

LIST OF FIGURES

Figure 1: Total Prevalent/Incident Cases of the Multiple Myeloma in 7MM
Figure 2: Total Prevalent/Incident Cases of the Multiple Myeloma in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Multiple Myeloma in United States
Figure 4: Sub-Type Specific Cases of the Multiple Myeloma in United States*
Figure 5: Sex- Specific Cases of the Multiple Myeloma in United States*
Figure 6: Diagnosed Cases of the Multiple Myeloma in United States
Figure 7: Treated Cases of the Multiple Myeloma in United States
Figure 8: Prevalent/Incident Cases of the Multiple Myeloma in Germany
Figure 9: Sub-Type Specific Cases of the Multiple Myeloma in Germany*
Figure 10: Sex- Specific Cases of the Multiple Myeloma in Germany*
Figure 11: Diagnosed Cases of the Multiple Myeloma in Germany
Figure 12: Treated Cases of the Multiple Myeloma in Germany
Figure 13: Prevalent/Incident Cases of the Multiple Myeloma in France
Figure 14: Sub-Type Specific Cases of the Multiple Myeloma in France*
Figure 15: Sex- Specific Cases of the Multiple Myeloma in France*
Figure 16: Diagnosed Cases of the Multiple Myeloma in France
Figure 17: Treated Cases of the Multiple Myeloma in United France
Figure 18: Prevalent/Incident Cases of the Multiple Myeloma in Italy
Figure 19: Sub-Type Specific Cases of the Multiple Myeloma in Italy*
Figure 20: Sex- Specific Cases of the Multiple Myeloma in Italy*
Figure 21: Diagnosed Cases of the Multiple Myeloma in Italy
Figure 22: Treated Cases of the Multiple Myeloma in Italy
Figure 23: Prevalent/Incident Cases of the Multiple Myeloma in Spain
Figure 24: Sub-Type Specific Cases of the Multiple Myeloma in Spain*
Figure 25: Sex- Specific Cases of the Multiple Myeloma in Spain*
Figure 26: Diagnosed Cases of the Multiple Myeloma in Spain
Figure 27: Treated Cases of the Multiple Myeloma in Spain
Figure 28: Prevalent/Incident Cases of the Multiple Myeloma in UK
Figure 29: Sub-Type Specific Cases of the Multiple Myeloma in UK*
Figure 30: Sex- Specific Cases of the Multiple Myeloma in UK*
Figure 31: Diagnosed Cases of the Multiple Myeloma in UK
Figure 32: Treated Cases of the Multiple Myeloma in UK
Figure 33: Prevalent/Incident Cases of the Multiple Myeloma in Japan
Figure 34: Sub-Type Specific Cases of the Multiple Myeloma in Japan*
Figure 35: Sex- Specific Cases of the Multiple Myeloma in Japan*
Figure 36: Diagnosed Cases of the Multiple Myeloma in Japan
Figure 37: Treated Cases of the Multiple Myeloma in Japan

*Indication Specific

Multiple Myeloma: Epidemiology Forecasting Intelligence

More Publications

Need Help?

Ask a Question

Market Reports